Growth Metrics

PAVmed (PAVM) Equity Ratio (2022 - 2025)

Historic Equity Ratio for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 0.85.

  • PAVmed's Equity Ratio changed N/A to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year change of. This contributed to the annual value of 0.23 for FY2024, which is 6836.93% up from last year.
  • PAVmed's Equity Ratio amounted to 0.85 in Q3 2025.
  • PAVmed's Equity Ratio's 5-year high stood at 0.86 during Q2 2025, with a 5-year trough of 1.03 in Q3 2023.
  • For the 4-year period, PAVmed's Equity Ratio averaged around 0.06, with its median value being 0.2 (2022).
  • As far as peak fluctuations go, PAVmed's Equity Ratio plummeted by 45802.51% in 2023, and later skyrocketed by 28077.16% in 2025.
  • Over the past 4 years, PAVmed's Equity Ratio (Quarter) stood at 0.2 in 2022, then crashed by 458.03% to 0.73 in 2023, then surged by 68.37% to 0.23 in 2024, then soared by 472.4% to 0.85 in 2025.
  • Its last three reported values are 0.85 in Q3 2025, 0.86 for Q2 2025, and 0.85 during Q1 2025.